Clinical Trial Update: Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial assessing effectiveness, immunogenicity, and safety of the Meningococcal ABCWY vaccine in healthy adolescents has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal ABCWY vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-06-26